Uromigos Live 2023: Dr. Mike Morris on Radioligands in Prostate Cancer

Uromigos Live 2023: Current and Future Status of Radioligand Therapy in Prostate CancerПодробнее

T Cell Directed Therapy in Prostate Cancer: Uromigos Live 2024Подробнее

Uromigos Live 2023: Dr. Vadim Koshkin on CheckMate 901Подробнее

Uromigos Live 2023: Dr. Anis Hamid on Where PSMAfore Sits In mCRPC SequencingПодробнее

Uromigos Live 2023: Where Do We Stand With PARP Inhibitors in Prostate Cancer?Подробнее

Radioligands: Uromigos Live 2024Подробнее

Uromigos Live 2024 Highlights: The Evolving Role of ADT in Prostate CancerПодробнее

Dr. Michael Morris on the Unique Format of The Uromigos: Live & UnpluggedПодробнее

Uromigos Live 2023: The Uromigos Cup Round 2Подробнее

Advancements in prostate cancer therapies from ASCO 2024Подробнее

Uromiogs Live 2023: Dr. Petros Grivas on Promising Future Treatments in Bladder CancerПодробнее

Uromigos Live 2023: Frontline Metastatic Renal Cancer: Time for ReflectionПодробнее

Uromigos Live 2023: The Uromigos Cup Round 1Подробнее

Uromigos Live 2023: Dr. Peter O'Donnell on the Excitement of a New Era in Bladder CancerПодробнее

The Uromigos Definition of Oligometastatic: Uromigos Live 2024Подробнее

Role of Medical Oncologists in prostate cancer managementПодробнее